3395F Quantitative nonher2 ihc brst cx
Other
Also known as: Non-HER2 IHC, hormone receptor testing, immunohistochemistry
Quantitative non-human epidermal growth factor receptor 2 immunohistochemistry evaluation of breast cancer tissue; pathologic assessment and quantification of non-HER2 protein expression by immunohistochemistry.
Clinical Context
Quality measure for testing of non-HER2 tumor markers in breast cancer. May include estrogen receptor, progesterone receptor, or other relevant markers for treatment planning.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.